News

Technology News

Illumina Unveils Market Expansion Roadmap

Friday, January 17, 2014 5:00:00 AM PDT | VentureDeal
   San Diego, California  --  Biotechnology company Illumina (NASDAQ: ILMN) revealed its plans for positioning itself for growth in key genomics segments.

The company plans to expand the use of its next-generation sequencing technology in reproductive health, oncology and in certain emerging markets.

Its products provide among the most efficient and simplest sequencing experience to its research and clinical customers, according to the firm.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1